Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wim Oyen

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Tracers to monitor the response to chemotherapy: in vitro screening of four radiopharmaceuticalsLioe-Fee de Geus-Oei, Julliëtte van Eerd-Vismale, Carla Molthoff, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2007
EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin)Jan Tennvall, Manfred Fischer, Angelika Bischof Delaloye, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2006
Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parametersMarinke Westerterp, Jan Pruim, Wim Oyen, et al.
Radiology. Imaging Cancer|January 24, 2025
Evaluation of Local Tumor Outcomes Following Microwave Ablation of Colorectal Liver Metastases Using CT Imaging: A Comparison of Visual versus Quantitative MethodsJoshua D Shur, Nuria Porta, Leila Kafaei, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionationMarcel Janssen, Cathelijne Frielink, Ingrid Dijkgraaf, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude ratsAdrienne Brouwers, Iris Verel, Julliëtte Van Eerd, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 21, 2017
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancerYong Du, Ignasi Carrio, Giuseppe De Vincentis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2010
111In-pentetreotide scintigraphy: procedure guidelines for tumour imagingEmilio Bombardieri, Valentina Ambrosini, Cumali Aktolun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2010
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATEIrene Virgolini, Valentina Ambrosini, Jamshed B Bomanji, et al.
Annals of Surgery|February 28, 2012
Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanomaEsther Bastiaannet, Carin A Uyl-de Groot, Adrienne H Brouwers, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Tracers to monitor the response to chemotherapy: in vitro screening of four radiopharmaceuticalsLioe-Fee de Geus-Oei, Julliëtte van Eerd-Vismale, Carla Molthoff, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2007
EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin)Jan Tennvall, Manfred Fischer, Angelika Bischof Delaloye, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2006
Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parametersMarinke Westerterp, Jan Pruim, Wim Oyen, et al.
Radiology. Imaging Cancer|January 24, 2025
Evaluation of Local Tumor Outcomes Following Microwave Ablation of Colorectal Liver Metastases Using CT Imaging: A Comparison of Visual versus Quantitative MethodsJoshua D Shur, Nuria Porta, Leila Kafaei, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionationMarcel Janssen, Cathelijne Frielink, Ingrid Dijkgraaf, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude ratsAdrienne Brouwers, Iris Verel, Julliëtte Van Eerd, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 21, 2017
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancerYong Du, Ignasi Carrio, Giuseppe De Vincentis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2010
111In-pentetreotide scintigraphy: procedure guidelines for tumour imagingEmilio Bombardieri, Valentina Ambrosini, Cumali Aktolun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2010
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATEIrene Virgolini, Valentina Ambrosini, Jamshed B Bomanji, et al.
Annals of Surgery|February 28, 2012
Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanomaEsther Bastiaannet, Carin A Uyl-de Groot, Adrienne H Brouwers, et al.
Pageof 3